Rapid DNA interstrand cross-linking of Pt(IV) compound
Author:
Funder
Tianjin Municipal Natural Science Foundation
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Pharmacology
Reference59 articles.
1. Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS-mutated metastatic colorectal cancer: the REVOLUTION study protocol;Avallone;Ther. Adv. Med. Oncol.,2020
2. Gene expression profiling reveals activation of the FA/BRCA pathway in advanced squamous cervical cancer with intrinsic resistance and therapy failure;Balacescu;BMC Cancer,2014
3. Formation of DNA adducts by the anticancer drug carboplatin: different nucleotide sequence preferences in vitro and in cells;Blommaert;Biochemistry,1995
4. The colibactin genotoxin generates DNA interstrand cross-links in infected cells;Bossuet-Greif;mBio,2018
5. DNA interstrand cross-linking agents and their chemotherapeutic potential;Brulikova;Curr. Med. Chem.,2012
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent updates in nanoscale delivery systems of platinum(IV) antitumor prodrugs;Coordination Chemistry Reviews;2024-06
2. Glycyrrhetinic Acid as a Hepatocyte Targeting Ligand-Functionalized Platinum(IV) Complexes for Hepatocellular Carcinoma Therapy and Overcoming Multidrug Resistance;Journal of Medicinal Chemistry;2024-05-10
3. Platinum-based drugs in cancer treatment: Expanding horizons and overcoming resistance;Journal of Molecular Structure;2024-04
4. Current Status of Novel Multifunctional Targeted Pt(IV) Compounds and Their Reductive Release Properties;Molecules;2024-02-06
5. Dual-targeting tumor cells hybrids derived from Pt(IV) species and NF-κB inhibitors enables cancer therapy through mitochondrial dysfunction and ER stress and overcomes cisplatin resistance;European Journal of Medicinal Chemistry;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3